News
12h
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...
While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
Morris told us he’s “not aware of any evidence” that COVID-19 vaccines increase the risk of stroke in children. He pointed to two studies, one looking at Vaccine Safety Datalink data from ...
There also was no link between miscarriage risk and the number of vaccinations a woman had gotten, or whether she’d gotten ...
A new study links growing vaccine skepticism to pet care. Lollypop Farm offers free rabies shots, food and vet access for dogs and cats in Rochester.
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government ... Kennedy Jr. has cast doubt on the safety of mRNA vaccines, but Moderna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results